Building a database to unlock wilson disease mysteries

NCT ID NCT03334292

Recruiting now Knowledge-focused Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study creates a registry for people diagnosed with Wilson disease, a rare genetic condition that causes copper buildup in the body. Researchers will collect medical data and biological samples over time to help future studies improve diagnosis and treatment monitoring. The goal is to build a resource that can answer key questions about the disease and support the development of new therapies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could help researchers find better ways to diagnose and monitor Wilson disease, potentially leading to improved treatments.
What could go wrong: This is an observational registry, not a treatment trial. It does not test any new therapy, so direct benefits for participants are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WILSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Wilson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

WILSON DISEASE

Contacts and locations

Locations

Advent Health
RECRUITING

Orlando, Florida, 32803, United States
Baylor College of Medicine
RECRUITING

Houston, Texas, 77030, United States
Royal Surrey Country Hospital
ACTIVE_NOT_RECRUITING

Guildford, Surrey, GU2, United Kingdom
Seattle Children's Hospital
ACTIVE_NOT_RECRUITING

Seattle, Washington, 98105, United States
Universitätsklinikum Heidelberg
RECRUITING

Heidelberg, 69120, Germany
Yale University
RECRUITING

New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.